biomx series B
Great news for BiomX, a company developing custom phage therapies to treat microbiome-based diseases, which just raised $32 million in series B financing!
Topics
Great news for BiomX, a company developing custom phage therapies to treat microbiome-based diseases, which just raised $32 million in series B financing!